Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Surgopaedia
Search
Search
Appearance
Create account
Log in
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Editing
Surveillance for DTC
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Approach == * Re-stratify patients each review (table under 'adjuvant therapy for DTC') * Emphasise response to therapy - by using USS and measurements of serum Tg * 'stimulated Tg' refers to whether or not the patient is having TSH suppression == '''Response to therapy definitions based on initial therapy''' == {| class="wikitable" | |'''Initial therapy''' | | |- | |'''Total thyroidectomy and RAI ablation''' |'''Total thyroidectomy without RAI ablation''' |'''Lobectomy''' |- |'''Excellent response''' |Nonstimulated Tg level <0.2 ng/mL* or stimulated Tg level <1 ng/mL* and undetectable TgAb and negative imaging |Nonstimulated Tg level <0.2 ng/mL* or stimulated Tg level <2 ng/mL* and undetectable TgAb and negative imaging |Stable, nonstimulated Tg level <30 ng/mL* and undetectable TgAb and negative imaging |- |'''Biochemical incomplete response''' |Nonstimulated Tg level >1 ng/mL* or stimulated Tg level >10 ng/mL* or increasing TgAb levels and negative imaging |Nonstimulated Tg level >5 ng/mL* or stimulated Tg level >10 ng/mL* or increasing Tg values over time with similar TSH levels or increasing TgAb levels and negative imaging |Nonstimulated Tg level >30 ng/mL* or increasing Tg level values over time with similar TSH levels or increasing TgAb levels and negative imaging |- |'''Structural incomplete response''' |Structural or functional evidence of disease regardless of Tg or TgAb |Structural or functional evidence of disease regardless of Tg or TgAb |Structural or functional evidence of disease regardless of Tg or TgAb |- |'''Indeterminate response''' |Nonspecific findings on imaging studies or faint uptake in thyroid bed on RAI scanning or nonstimulated Tg level 0.2-1 ng/mL* or stimulated Tg level 1-10 ng/mL* or TgAb levels stable or declining in the absence of structural or functional disease |Nonspecific findings on imaging studies or faint uptake in thyroid bed on RAI scanning or nonstimulated Tg level 0.2-5 ng/mL* or stimulated Tg level 2-10 ng/mL* or TgAb levels stable or declining in the absence of structural or functional disease |Nonspecific findings on imaging studies or TgAb levels stable or declining in the absence of structural or functional disease |} == '''Differentiated thyroid cancer: Monitoring during the first year after thyroid surgery''' == {| class="wikitable" | |'''Risk of recurrence''' | | |- | |'''Low''' |'''Intermediate''' |'''High''' |- |'''Nonstimulated Tg*''' |4 to 6 weeks 3 to 6 months 9 to 12 months |4 to 6 weeks 3 to 6 months 9 to 12 months |4 to 6 weeks 3 to 6 months 9 to 12 months |- |'''Neck ultrasound''' |At 6 to 12 months |At 6 to 12 months |Every 6 to 12 months |- |'''Diagnostic WBS''' |Usually not indicated |Case specific |Case specific |- |'''MRI, CT''' |Not indicated |Not indicated |If Tg elevated or high clinical suspicion |- |'''FDG-PET''' |Not indicated |Not indicated |If Tg >10 ng/mL |- |'''Serum TSH goal''' |0.1 to 0.5 mU/L if nonstimulated Tg detectable 0.5 to 2.0 mU/L if nonstimulated Tg undetectable |0.1 to 0.5 mU/L |<0.1 mU/L |} == '''Differentiated thyroid cancer: Ongoing monitoring''' == {| class="wikitable" | |'''Response to therapy''' | | | |- | |'''Excellent''' |'''Biochemical incomplete''' |'''Structural incomplete''' |'''Indeterminate''' |- |'''Nonstimulated Tg''' |Every one to two years |Every six months |Every six months |6 to 12 months |- |'''Stimulated Tg''' |Not needed |May be repeated at two- to three-year intervals if needed to establish an excellent response to therapy |Not needed |May be repeated at two- to three-year intervals if needed to establish an excellent response to therapy |- |'''Neck ultrasound''' |Consider at three- to five-year intervals |Yearly for five years |Yearly for five years |6- to 12-month intervals for five years |- |'''Diagnostic WBS''' |Not indicated |Not usually done* |To evaluate RAI avidity of structural disease |Not usually done* |- |'''MRI, CT''' |Not indicated |Not indicated* |6- to 12-month intervals depending on rate of progression |Not indicated* |- |'''FDG-PET''' |Not indicated |Not indicated* |To identify additional sites of disease and for prognostic purposes |Not indicated* |- |'''Serum TSHยถ''' |0.5 to 2 mU/L |0.1 to 0.5 mU/L |<0.1 mU/L |0.1 to 0.5 mU/L |} [[Category:Endocrine]]
Summary:
Please note that all contributions to Surgopaedia may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Surgopaedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Surveillance for DTC
Add topic